A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled, study to evaluate the efficacy
and safety of oral ivermectin tablets versus placebo for COVID-19 prophylaxis